
News|Articles|February 1, 2003
Atorvastatin may inhibit clopidogrel activity
Ann Arbor, Mich-Atorvastatin, especially at higher dosages, may prevent activation of the antiplatelet agent clopidogrel, according to research at the University of Michigan, Ann Arbor.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Part D redesign reshapes market
2
The sleep doctor who lives with a disorder he treats
3
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
4
Recombinant shingles vaccine linked to lower cardiovascular disease risk
5











